Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ02102
Drozitumab
912628-39-8
95%
CFZ02101
Intetumumab
725735-28-4
95%
CFZ02100
Nacolomab Tafenatox
150631-27-9
95%
CFZ02099
Nerelimomab
162774-06-3
95%
CFZ02098
Zolimomabaritox
141483-72-9
95%
CFZ02097
Vepalimomab
195158-85-1
95%
CFZ02096
Minretumomab
195189-17-4
95%
CFZ02095
Maslimomab
127757-92-0
95%
CFZ02094
Bectumomab
158318-63-9
95%
CFZ02093
Rovelizumab
339086-79-2
95%
Home
<<
···
50
51
52
53
54
···
52/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877